Gains in speed, flexibility, and agility are essential for drug and vaccine manufacturers. One innovative solution is the design and construction of manufacturing facilities using predesigned and prefabricated elements. These modular facilities respond to global demand for new medicines while overcoming the lack of predictability and flexibility that have historically burdened manufacturers. This webinar describes the collaboration of our company and G-Con to develop a proof-of-concept facility design that enables multi-modal bioprocessing, including our process equipment, with greater flexibility and response time and facilitates tech transfer and future expansion. Details about the design, timelines, and costs will be included.
In this webinar, you will learn:
- How to develop a proof-of-concept facility design that supports multi-modal bioprocessing
- Details about the specific design, timelines, and costs
- How this modular facility approach can be leveraged for your specific requirements
Speakers
Jérome Dalin
Merck
Associate Director – Alliance Management, BioContinuum™ Business Franchise
Jerome Dalin holds an Msc/engineering degree in industrial manufacturing and biological engineering. He started his career at Sanofi Pasteur 21 years ago, focusing on vaccine process development in France, Canada & USA. In 2013, he joined our company to manage bioprocessing sales and later transitioned to the Strategy organization to lead global initiatives for vaccines and the Factory of the Future. In his current role, Jerome is at the helm of Alliance Management, driving the development of the BioContinuum™ platform across the biopharmaceutical industry.
Thomas Hauser
G-CON Manufacturing
Business Development Manager EMEA
Thomas Hauser works for G-CON Manufacturing in business development within the EMEA region. He works to educate the market for offsite prefabricated and prequalified factory and clean-room solutions in a drive to bring forward the pharmaceutical facility of the future. He also supports companies in the life science segment, mainly for expansion strategies, strategic facility implementation, start-up support, and pharmaceutical packaging supply and technologies.
Before 2020, Thomas worked in various leading global positions in business development, strategic implementation, and sales in the pharmaceutical packaging field, namely in injectables, semi-solid and oral-solid packaging. He has more than 25 years of experience dealing with the global life science Industry and its market and manufacturing requirements. Thomas holds an international MBA from the University of Ottawa / Canada, and a BA in European business from the ESB Reutlingen and the ESC Reims.
Pharma and biopharma manufacturing
- Pharma and biopharma manufacturing
Durée:1h
Langue:English
Session 1:présenté(e) December 1, 2022
Pour continuer à lire, veuillez vous connecter à votre compte ou en créer un.
Vous n'avez pas de compte ?